LILRB1 anticorps (Biotin)
-
- Antigène Voir toutes LILRB1 Anticorps
- LILRB1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp LILRB1 est conjugé à/à la Biotin
-
Application
- Flow Cytometry (FACS)
- Purification
- The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions. The solution is free of unconjugated biotin.
- Clone
- GHI-75
- Isotype
- IgG2b kappa
- Top Product
- Discover our top product LILRB1 Anticorps primaire
-
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) antibody
LILRB1 Reactivité: Humain WB, FACS, IP Hôte: Souris Monoclonal GHI-75 unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) antibodyLILRB1 Reactivité: Humain WB, FACS, IP, Func Hôte: Souris Monoclonal GHI-75 unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) (AA 338-461) antibodyLILRB1 Reactivité: Humain WB, ELISA, FACS Hôte: Souris Monoclonal 4B5A4 unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) (AA 483-650) antibodyLILRB1 Reactivité: Humain WB, ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) (AA 18-650) antibodyLILRB1 Reactivité: Humain WB, ELISA Hôte: Souris Monoclonal 3D3-1D12 unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) antibodyLILRB1 Reactivité: Humain ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) antibody (PE)LILRB1 Reactivité: Humain FACS Hôte: Souris Monoclonal GHI-75 PE
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) (AA 1-650) antibodyLILRB1 Reactivité: Humain WB, IP Hôte: Lapin Polyclonal unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) (N-Term) antibodyLILRB1 Reactivité: Humain WB, ELISA Hôte: Lapin Polyclonal unconjugated
anti-Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1) (AA 223-410) antibodyLILRB1 Reactivité: Humain WB, ELISA, ICC, IHC (fro), IHC (p) Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Concentration
- 0.5 mg/mL
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Do not freeze.
- Stock
- 4 °C
- Stockage commentaire
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Antigène
- LILRB1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))
- Autre désignation
- CD85j (LILRB1 Produits)
- Synonymes
- anticorps CD85J, anticorps ILT-2, anticorps ILT2, anticorps LIR-1, anticorps LIR1, anticorps MIR-7, anticorps MIR7, anticorps leukocyte immunoglobulin like receptor B1, anticorps LILRB1
- Sujet
- CD85 is a group of Ig superfamily tansmembrane glycoproteins called Ig-Like Transcripts (ILTs) or Leukocyte Immunoglobulin-like Receptors (LIRs). CD85j is the 110kD member, known as ILT2, LIR1, or LILRB1, and MIR7. ILT2 structurally has four Ig domains and contains ITIMs in its cytoplasmic tail that provide inhibitory signals by recruiting SHP-1. ILT2 is found on the surface of B cells, plasma cells, dendritic cells, monocytes, subsets of NK and T cells. The ligands of ILT2 include a broad range of HLA-A, -B molecules, some HLA-C and HLA-G molecules, and the human cytomegalovirus UL18 protein.
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-
